BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21164047)

  • 1. Atypical plexiform neurofibroma in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin.
    Friedrich RE; Derlin T; Hagel C
    In Vivo; 2010; 24(6):871-6. PubMed ID: 21164047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.
    Friedrich RE; Gawad K; Derlin T; Zustin J; Hagel C
    Anticancer Res; 2012 Oct; 32(10):4547-51. PubMed ID: 23060584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma.
    Naber U; Friedrich RE; Glatzel M; Mautner VF; Hagel C
    J Neurooncol; 2011 Jun; 103(2):239-45. PubMed ID: 20821344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
    Tsai LL; Drubach L; Fahey F; Irons M; Voss S; Ullrich NJ
    J Neurooncol; 2012 Jul; 108(3):469-75. PubMed ID: 22407214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
    Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
    Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation in a sciatic plexiform neurofibroma in Neurofibromatosis Type 1 - imaging features that aid diagnosis.
    Chew DCY; Zhao DBH; Sittampalam K; Kumar SK
    J Radiol Case Rep; 2020 Dec; 14(12):1-13. PubMed ID: 33717399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
    Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
    Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
    Friedrich RE; Nörnberg LKN; Hagel C
    Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
    Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
    J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.
    Uthoff J; De Stefano FA; Panzer K; Darbro BW; Sato TS; Khanna R; Quelle DE; Meyerholz DK; Weimer J; Sieren JC
    J Neuroradiol; 2019 May; 46(3):179-185. PubMed ID: 29958847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
    Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B
    Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [
    Azizi AA; Slavc I; Theisen BE; Rausch I; Weber M; Happak W; Aszmann O; Hojreh A; Peyrl A; Amann G; Benkoe TM; Wadsak W; Kasprian G; Staudenherz A; Hacker M; Traub-Weidinger T
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28771999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1.
    Ozcan HN; Karcaaltincaba M; Oguz B; Haliloglu M
    Clin Radiol; 2014 Apr; 69(4):431-5. PubMed ID: 24361143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
    Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
    Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.
    Moharir M; London K; Howman-Giles R; North K
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1309-17. PubMed ID: 20179923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
    Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
    PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM
    Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.